D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia
Clinical trial NCT02744768 · UNKNOWN
Trial details
- NCT number
- NCT02744768
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-31
- Primary completion
- 2021-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.